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ABSTRACT
The crystal structures of six complexes between
aminoglycoside antibiotics (neamine, gentamicin
C1A, kanamycin A, ribostamycin, lividomycin A and
neomycin B) and oligonucleotides containing the
decoding A site of bacterial ribosomes are reported
at resolutions between 2.2 and 3.0 A ˚. Although the
number of contacts between the RNA and the
aminoglycosides varies between 20 and 31, up to
eight direct hydrogen bonds between rings I and II
of the neamine moiety are conserved in the observed
complexes. The puckered sugar ring I is inserted into
theAsitehelixbystackingagainstG1491andformsa
pseudo base pair with two H-bonds to the Watson–
Crick sites of the universally conserved A1408. This
centralinteractionhelpstomaintainA1492andA1493
in a bulged-out conformation. All these structures of
the minimal A site RNA complexed to various
aminoglycosides display crystal packings with inter-
molecular contacts between the bulging A1492 and
A1493 and the shallow/minor groove of Watson–
Crick pairs in a neighbouring helix. In one crystal,
one empty A site is observed. In two crystals, two
aminoglycosides are bound to the same A site with
oneboundspecificallyandtheotherboundinvarious
ways in the deep/major groove at the edge of the A
sites.
INTRODUCTION
Aminoglycosides are broad spectrum bactericidal antibiotics
which are used against Gram-negative bacteria such as
Escherichia coli and some Gram-positive bacteria such as
those of the Staphylococcus family. They disturb the ﬁdelity
of the tRNA selection step during protein synthesis by binding
to the A site on the bacterial ribosome 16S rRNA (1,2). The
aminoglycoside antibiotics are oligosaccharides containing
variable numbers of sugar rings and ammonium groups (3).
They all contain a central 2-deoxystreptamine (2-DOS or ring
II) with an ammonium group on either side of the deoxy
carbon and attached at position 4 to ring I, forming the neam-
ine molecule. The different sub-classes can be distinguished
on the basis of the chemical linkages to ring II: in the neo-
mycin family (containing paromomycin, neomycin B, livido-
mycin A and ribostamycin), ring II is 4,5-disubstituted and, in
the kanamycin and gentamicin families (to which tobramycin,
geneticin and gentamicin C1A belong), ring II is 4,6-
disubstituted (Figure 1).
A critical advance in the understanding of molecular recog-
nition and the mechanisms of action has recently been made
with the high-resolution crystal structures (3.1 A ˚) of bacterial
ribosomal 30S particles complexed to aminoglycosides (4–7).
In addition, crystal structures were solved for the decoding-
aminoacyl site (A site) (2.4–2.54 A ˚), isolated from the
bacterial ribosome 16S rRNA, and complexed with several
antibiotics from the aminoglycoside family (8–10). The crys-
talline complexes between RNA oligonucleotides containing
two A sites (Figure 2) and paromomycin, tobramycin or
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doi:10.1093/nar/gki862geneticin characterized the binding mode of aminoglycosides
athighresolution.Thepuckered sugarringIisinsertedintothe
A site helix by stacking against a guanine residue (G1491) and
by forming a pseudo pair with two H-bonds to the Watson–
Crick sites of an universally conserved adenine (A1408). This
particular interaction helps to maintain adenines A1492 and
A1493 in the bulged-out conformation which allows those two
adenines to make A-minor contacts with two Watson–Crick
base pairs. In the 30S particle, the two contacted Watson–
Crick base pairs belong to the ﬁrst two pairs of the codon-
anticodon minihelix (4–6). In the co-crystal structures, the two
contacted Watson–Crick base pairs belong to a neighbouring
complex, mimicking the situation occurring in the 30S particle
(8,11). This locked conformation of the bulging A1492 and
A1493 in the docked complex forms the molecular basis for
the aminoglycoside induced misreading (5,12). The conserved
2-deoxystreptamine ring (ring II) forms similar H-bonds in the
three complexes and its binding is made possible by the adapt-
ability created by the universally conserved U1406·U1495
pair. The additional rings contact different nucleotides of
the A site, depending on the substitution type of ring II.
Thus, overall tight packing of atoms in direct van der
Waals contact is central and a prerequisite to speciﬁc recog-
nition. About one third of the total RNA-aminoglycoside
Figure 1. Chemical structures of the three aminoglycoside subclasses studied in this work. The common 2-deoxystreptamine ring is coloured in blue and the
substituted positions are numbered in bold.
Figure 2. Left: secondary structure of the minimal A site. The standard E.coli
numbering is used. Right: secondary structure of the crystallized RNA helix.
The two A sites are boxed and the 50-dangling UU, usually not observed in the
density maps, are shaded.
5678 Nucleic Acids Research, 2005, Vol. 33, No. 17contacts were shown to be mediated by water molecules (11).
Water molecules participate in the assembly by linking hydro-
philic groups that belong to both components. The hydration
shells around nucleic acid base pairs tend to be conserved and
maintained regardless of the environment (13,14).
Here, we present six crystal structures of complexes
between A site oligonucleotides and aminoglycoside antibiot-
ics containing between two and ﬁve aminosugar rings: neam-
ine (2.5 A ˚), ribostamycin (2.2 A ˚), kanamycin A (3.0 A ˚),
gentamicin C1A (2.8 A ˚), neomycin B (2.4 A ˚) and lividomycin
A (2.2 A ˚) (Supplementary Table 1). Those crystal structures
fully conﬁrm the conservation of contacts between aminoglyc-
osides and A site nucleotides despite the great molecular vari-
ety: eight direct contacts between the neamine rings and the A
site nucleotides are present in every single crystal structure. In
addition and following the molecular diversity, the complexes
display various additional contacts, either direct or water-
mediated to the neamine moiety as well as to the additional
rings. The crystal structures also show that the occupancy at
the binding site can be variable. Thus, in the neamine crystal
structure, one of the two A sites is empty; in the kanamycin
complex, one A site contains two bound antibiotics; and, in the
ribostamycin complex, both A sites contain two bound anti-
biotics. Overall, the stoichiometry of aminoglycoside binding
is observed to vary between zero and two per A site, an
important fact which needs to be incorporated in the appre-
ciation of the measured binding constants on model oligonuc-
leotide systems and in their comparisons with structural data.
MATERIALS AND METHODS
Crystallization procedures are essentially the same as pub-
lished previously (8–10). Two RNA constructs were used
for crystallization trials: 50-CGCGUCACACCGGUGAA-
GUCGC-30 and 50-UUGCGUCACACCGGUGAAGUCGC-
30. These were purchased from Dharmacon Research, Inc
(Boulder, CO) and puriﬁed by denaturing gel electrophoresis
[20%(w/v) acrylamide/bisacrylmamide (19:1), 8 M urea]
using TBE buffer [9 mM Tris-borate (pH 8.3) and 0.2 mM
EDTA] at 50–55 C. The appropriate band was excised, eluted
into 300 mM Sodium Acetate pH 5.2 and recovered by pre-
cipitation with iso-propanol. The RNA was exchanged and
concentrated to 2.0 mM into 100 mM Sodium Cacodylate
pH 6.4, 50 mM Sodium Chloride, 5.125 mM Magnesium
Sulphate and 0.125 mM EDTA. Before crystallization the
RNA was annealed by heating at 90 C for 2 min and then
slowly cooled to 37 C. Antibiotics were purchased from
Sigma, and made up to 4 mM in 200 mM Sodium Cacodylate
pH 6.4 and 300 mM Potassium Chloride. Equal volumes of
RNA and antibiotic solution were combined and incubated at
37 C for 10 min before crystallization. Crystallization was
performed by the hanging drop method as follows, 1 mlo f
RNA/antibiotic solution was combined with 1 ml of crystal-
lization solution (1–5% MPD and 1–5% glycerol) and equi-
librated over a 50% MPD (Fluka) reservoir.
The best crystals were recovered and vitriﬁed in liquid
ethane (110 K) or nitrogen (77 K) after soaking brieﬂy in
12.5 mM Sodium Chloride, 125 mM Sodium Cacodylate
pH 6.4, 150 mM Potassium Chloride, 2 mM Antibiotic and
40% MPD.
Data collection was performed on the Structural Biology
Beamline ID29 at the European Synchrotron Radiation Facil-
ity (ESRF; Grenoble, France). Data were processed with the
HKL2000 suite (15) and a correct solution was found for each
structure by the molecular replacement program Molrep (16)
using the coordinates of the RNA from PDB code 1J7T (paro-
momycin). Reﬁnement was done using CNS version 1.1 (17).
The parameter and topology ﬁles for the antibiotic molecules
were obtained on the Hetero-compound Information Centre—
Uppsalaserver (18)(UniversityofUppsala,Sweden).Thedata
pertaining to data collection and reﬁnement are given in
Supplementary Table 1. Each crystallized duplex contains
two identical but independent A sites. In all complexes, one
of the two A sites is always better deﬁned structurally (lower
temperature factors, more identiﬁed solvent peaks). The struc-
ture of the complex with neamine has been reﬁned at 2.8 A ˚ as
well as in the presence of modiﬁed neamine molecules
(J.B. Murray, S.O. Meroueh, R.J.M. Russell, G. Lentzen,
J. Haddad, S. Mobashery, submitted) (19). Here we extended
the reﬁnement to 2.5 A ˚. In all ﬁgures below, only the better
deﬁned A site is used for representation. All ﬁgures were
drawn using The PyMOL Molecular Graphics system (2002)
DeLano Scientiﬁc, San Carlos, CA (http://www.pymol.org).
RESULTS
First, the complexes that display the same main characteristics
as the previously published ones will be described. That sec-
tion will be followed by the complexes displaying non-
speciﬁcally bound antibiotics. The crystal structure of the
complex between neamine and the RNA oligonucleotide is
discussed separately owing to its peculiarities. Finally, there
is a description of the crystal packing contacts and of their
importance.
Standard complexes
The complexes are described with increasing number of rings
additional to the neamine moiety. Supplementary Tables 2A–
C contains a list of hydrogen bonding contacts, direct or water-
mediated, between the rings of the aminoglycosides and the
RNA duplex. In Supplementary Table 3, the root-mean-
square-deviations (RMSD) of the RNA duplexes in all the
complexes are shown. When considering only the minimal
A site nucleotides, the RMSD values are between 0.4 and
0.9 A ˚, independently of the nature of the 4,5 or 4,6 linkage.
When considering all atoms of the RNA duplexes, the values
are slightly higher and tend to be a little higher when com-
paring 4,5 and 4,6 substituted aminoglycosides (but still less
than 1.2 A ˚). Such comparisons cannot include the complex
with neamine (see below). The comparisons are made with
respect to the paromomycin complex (8) which is the only A
site bound aminoglycoside solved also within the context of
the 30S particles (7). We showed before (8) that the RMSDs
between the complexed oligonucleotide crystals and the com-
plexed 30S particles are less than 1 A ˚. Comparisons between
the RNA alone structures of the present complexes and the A
site RNA in the paromomycin bound 30S particles (7) are also
around 1 A ˚.
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The gentamicin C1A is a 4,6 aminoglycoside very closely
related to geneticin (also known as gentamicin G or G418).
The differences are in ring I where the important 60 substitu-
ent is an ammonium group and carbons 30 and 40 are deoxy.
Six of the eight invariant intermolecular contacts between
rings I and II are present, the two missing ones being those
involving the hydroxyl groups at the 30 and 40 positions.
Of those six, four are absent in the NMR structure (distan-
ces above 3.5 A ˚) (20). Such differences have been discussed
previously (8,21). Four contacts are common in both genta-
micin C1A and geneticin crystals (10) (Figure 3 and Supple-
mentary Tables 2A–C). The U1495·U1406 base pair is
bifurcated with a H-bond between O400 and O2P(U1406) as
in geneticin. The intramolecular H-bond between N20 and O5
linking rings II and I is water-mediated in geneticin and direct
in gentamicin, while the other intramolecular H-bond,
between O5 and O500 linking rings I and III are direct in
both. The RMSD between the X-ray and NMR structure
(20) is 2.3 A ˚ while the RMSD between the present X-ray
complex and the paromomycin bound to the 30S particle
(7) is 1.0 A ˚.
Neomycin B
Neomycin B is a 4,5 aminoglycoside which differs from
paromomycin by the presence of an ammonium group instead
of a hydroxyl group at position 60. It thus carries six positive
charges, being the aminoglycoside with the highest charge.
The number of aminoglycoside/RNA contacts is about the
same in paromomycin and neomycin, respectively, (23,24)
with 15 common factors (Figure 4 and Supplementary Tables
2A–C). Again, the U1495·U1406 base pair is bifurcated with a
water mediated contact between O4(U1406) and O6 of ring II
instead of a direct H-bond as in gentamicin and geneticin.
Figure3.DescriptionandanalysisofthecontactsbetweengentamicinC1AandtheRNAfragment.(A)StructureadoptedbythegentamicinC1Amoleculeinsidethe
A site of the duplex. Ring numbers (I–III) and atom names are specified. The E.coli numbering is used for the RNA atoms, and ‘W’ stands for water molecule.
Hydrogen bonds are shown as dashed lines. Conserved contacts between gentamicin C1A and the minimal A site are shown in red. (B–F) Atomic details of the
contacts involving each base pair of the minimal A site interacting with gentamicin C1A.
5680 Nucleic Acids Research, 2005, Vol. 33, No. 17The two intramolecular H-bonds linking N20 of ring I to O400
and O500 of ring II are identical.
Lividomycin A
Lividomycin A is also a 4,5 aminoglycoside but with ﬁve
rings, the most substituted compound we have analysed. Posi-
tion 60 contains a hydroxyl group with a deoxy at position 30.
The last ring does not carry any positive charge and, thus, the
overall charge is +5 like gentamicin. The resolution is among
the highest of the crystals analysed (2.2 A ˚). Not surprisingly,
the number of RNA/aminoglycoside contacts is high, 31, but
with only 9 or 11 common between lividomycin and paromo-
mycin or neomycin, respectively. Some of the differences can
be ascribed to a conformational change of the phosphate of
A1493 leading to an alternative hydration network between
the neamine part and the RNA (Figure 5). In the complex of
geneticin,thisalternativeconformer ofA1493wasobserved in
Figure4.DescriptionandanalysisofthecontactsbetweenneomycinBandtheRNAfragment.(A)StructureadoptedbytheneomycinBmoleculeinsidetheAsiteof
theduplex.Ringnumbers(I–IV)andatomnamesarespecified.TheE.colinumberingisusedfortheRNAatoms,and‘W’standsforwatermolecule.Hydrogenbonds
areshownasdashedlines.ConservedcontactsbetweenneomycinBandtheminimalAsiteareshowninred.(B–F)Atomicdetailsofthecontactsinvolvingeachbase
pair of the minimal A site interacting with neomycin B.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5681Figure 5. DescriptionandanalysisofthecontactsbetweenlividomycinAandtheRNAfragment.(A)StructureadoptedbythelividomycinAmoleculeinsidetheA
siteoftheduplex.Ringnumbers(I–V)andatomnamesarespecified.TheE.colinumberingisusedfortheRNAatoms,and‘W’standsforwatermolecule.Hydrogen
bondsareshownasdashedlines.ConservedcontactsbetweenlividomycinAandtheminimalAsiteareshowninred.(B–F)Atomicdetailsofthecontactsinvolving
each base pair of the minimal A site interacting with lividomycin A.
5682 Nucleic Acids Research, 2005, Vol. 33, No. 17equilibrium with the regularly seen conformer. Again, the
U1495·U1406 base pair is bifurcated with two bound water
molecules, one linking the RNA to the aminoglycoside and the
other one bound to U1406. The hydroxyl groups of ring V
contacts only single anionic phosphate oxygen atoms.
Complexes with both specific and non-specific binding
Two complexes displayed unexpected stoichiometries. In the
crystal structure of the complex between kanamycin and the
oligonucleotide, one A site contained a single antibiotic as
usual but the second A site (with the lowest B-factors) presen-
ted two bound aminoglycosides, one in the standard binding
mode and the second one in a new binding mode (Figure 6A).
Further, in the complex between ribostamycin and the oligo-
nucleotides, both A sites contained two bound aminoglycos-
ides, one inthe standardbindingmode andthe otherone stillin
another binding mode (Figure 6B). We refer to these addi-
tional binding modes as ‘unspeciﬁc’ binding modes not only
order to distinguish the binding modes but also because of the
diversity in the binding modes of the ‘unspeciﬁc’ ones.
Kanamycin A
Kanamycin A is a 4,6 aminoglycoside with two changes com-
pared to tobramycin: there is a hydroxyl group at position 30
and position 20 contains a hydroxyl group instead of an ammo-
nium group as in tobramycin. Thus, overall, kanamycin
carries four positive charges instead of ﬁve charges. Tobra-
mycin and kanamycin present, respectively, 21 and 20 RNA/
aminoglycoside contacts. Of those, eight contacts belong to
the common and usual eight invariant contacts (Figure 7). In
the best deﬁned A site, there is a second kanamycin molecule
straddling the entrance of the deep/major groove (Figure 7G).
Theconformationsofthespeciﬁcallyandunspeciﬁcallybound
kanamycin molecules are almost identical (RMSD of 0.5 A ˚
with the RMSD between the two speciﬁcally bound kanamy-
cin equal to 0.2 A ˚). The substituents on the rings make
single H-bonds, six to water molecules and 5 to the RNA
(Figure 7H). The two kanamycin molecules do not contact
each other directly, but do interact via water molecules in
an interesting fashion: the hydroxyl group O400 of ring III
binds a water molecule which links O20 and O5 of rings I
and II, respectively. Although dimeric aminoglycosides
have been synthesized (22,23), it could be interesting attempt-
ing to synthesize dimeric molecules able to mimic the two
crystallographic bound molecules observed in the present
crystal structure.
Ribostamycin
Ribostamycin isa 4,5 aminoglycoside,equivalent to neomycin
without ring IV. It, thus, carries only four positive charges.
Comparedto neomycinwhich makes23 RNA/aminoglycoside
contacts, the speciﬁcally bound ribostamycin makes 21 but,
among those, 13 are common to both complexes (Figure 8 and
Supplementary Tables 2A–C): the hydroxyl O500 of ring III,
instead of H-bonding to N7(G1491), H-bonds to O6(G1491).
As discussed above, in both A sites, two ribostamycin
molecules are bound (Figure 8G). The conformers of the
ribostamycin molecules, the speciﬁcally and the unspeciﬁcally
bound ones, are almost identical (RMSD speciﬁc-
unspeciﬁc ¼ 0.8 A ˚, RMSD speciﬁc-speciﬁc ¼ 0.4 A ˚). In con-
trast to the situation observed in the kanamycin complex, the
ribostamycin molecules face each other with their rings III but
Figure 6. Specific and ‘non-specific’ binding modes of aminoglycosides. (A) Overall view of crystallized kanamycin A complex. (B) Overall view of crystallized
ribostamycin complex. In both structures, the specifically bound antibiotics are coloured in yellow ball and sticks and the ‘non-specifically’ bound antibiotics are
coloured in cyan ball and sticks.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5683Figure 7. Specific binding of kanamycin A. (A) Structure adopted by the specific kanamycin molecule coloured in yellow ball and sticks inside the A site of the
duplex.Ringnumbers(I–III)andatomnamesarespecified.TheE.colinumberingisusedfortheRNAatoms,and‘W’standsforwatermolecule.Hydrogenbondsare
shownindashedlines.ConservedcontactsbetweenspecifickanamycinandtheminimalAsiteareshowninred.(B–F)Atomicdetailsofthecontactsinvolvingeach
basepairoftheminimalAsiteinteractingwiththetwokanamycinmolecules.(G)Positionofthenon-specificallyboundkanamycin(colouredincyanballandsticks)
attheentranceofthedeep/majorgrooveoftheAsiteduplex.Thespecificmoleculeofkanamyciniscolouredinyellowlines.(H)Contactsmadebythe‘non-specific’
kanamycin,Ringnumbers(I–III)andatomnamesarespecified.TheE.colinumberingisusedfortheRNAatoms,and‘W’standsforwatermolecule.Hydrogenbonds
are shown as dashed lines.
5684 Nucleic Acids Research, 2005, Vol. 33, No. 17Figure 8. Specificand‘non-specific’bindingofribostamycin.(A)Structureadoptedbythespecificribostamycinmoleculecolouredinyellowballandsticksinside
the A site of the duplex. Ring numbers (I–III) and atom names are specified. The E.coli numbering is used for the RNA atoms, and ‘W’ stands for water molecule.
Hydrogenbondsareshownasdashedlines.(B–C)ConservedcontactsbetweenspecifickanamycinandthefirsttwobasepairsoftheminimalAsiteareshowninred.
(D–F)AtomicdetailsofthecontactsinvolvingthebasepairsoftheminimalAsiteinteractingwiththetworibostamycinmolecules.(G)Positionofribostamycinnon-
specifically bound (coloured in cyan ball and sticks) at the entrance of the deep/major groove of the duplex. The specifically bound molecule of ribostamycin is
colouredinyellowlines.(H)Contactsmadebythe‘non-specific’ribostamycin,Ringnumbers(I–III)andatomnamesarespecified.TheE.colinumberingisusedfor
the RNA atoms, and ‘W’ stands for water molecule. Hydrogen bonds are shown as dashed lines.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5685do not contact each other, even via water molecules (although
this cannot be formally excluded owing to the moderate res-
olution).Onthe contrary,the tworibostamycin molecules bind
to common nucleotides of the A site: the O300 and O200 of ring
III interacts with N6 and N7 of A1408 as well as with N4 and
O2P of C1409, respectively, (Figure 8E, F and H). Rings I and
II of the unspeciﬁcally bound ribostamycin interacts with nuc-
leotides ‘below’ the conserved region of the A site (1412,
1488, 1489) (Figure 8H).
The complex with neamine: variable occupancy
The crystal structure of the complex between neamine and the
oligonucleotides is the most peculiar one. All the standard
direct H-bonds between the neamine rings and the RNA are
present with the two A1492 and A1493 bulging out as in all
other complexes (Figure 9). However, U1406 does not form a
base pair with U1495 but, instead, bulges out of the duplex.
The place normally occupied by U1406 is ﬁlled in by an
Figure 9. Description and analysis of the contacts between neamine and the RNA fragment. (A) Overall view of the crystallized complex. Site 1 contains one
neamine in yellow. In both sites, A1408 are coloured in dark blue, A1492 in green, A1493 in cyan, U1406 in orange (which makes intermolecular contacts with
C1405-G1491)andU1495inmagenta[whichmakescontactswithA1492ofsite2ofasymmetricmolecule,see(D)].(B)Ringnumbers(IandII)andatomnamesare
specified. The E.coli numbering is used for the RNA atoms, and ‘W’ stands for water molecule. Hydrogen bonds are shown as dashed lines. Conserved contacts
between neamine and the minimal A Site are shown in red. (C–F) Atomic details of the contacts involving each base pair interacting with neamine in site 1.
5686 Nucleic Acids Research, 2005, Vol. 33, No. 17A1492 from a neighbouring molecule, forming a cis Watson–
Crick/Hoogsteen pair (with the adenine in the syn conforma-
tion). The second site is void of antibiotic and adenine A1408
forms a single H-bond pair with A1493 in the syn conforma-
tion (Figure 10C), while the U1406·U1495 base pair is fully
symmetric. Only A1492 bulges out (and H-bonds to a neigh-
bouring molecule U1495, as just described). Such a conforma-
tion with the bulging U1406 is compatible with the
conformation of the A site in the 30S ribosomal particle com-
plexed to tRNA and mRNA (6) (Supplementary Figure 1). An
isomorphous structure was obtainedfor complexes with neam-
ine at a lower resolution as well as with modiﬁed neamine
molecules (J.B. Murray, S.O. Meroueh, R.J.M. Russell,
G. Lentzen, J. Haddad, S. Mobashery, submitted) (19). Inter-
estingly, in crystals of oligonucleotides containing a single A
site (24), an equilibrium between the ﬂipped out conformation
of both A1492 and A1493 and a conformation with only
A1493 ﬂipped out was observed. The latter conformation is
different from the one observed in the free A site of the neam-
ine complex, since a cis Watson–Crick between A1408 and
A1492 was observed (24). Thus, the free A site exists in
multipleandalternativeconformationsincontrasttotheamino-
glycoside complexed A site, as observed previously (7,24).
Crystal packing: Adenines 1492 and 1493 bulge out of
the A site helix to form A-minor contacts with the
first two base pairs of the codon–anticodon
The previous structures of the minimal A site RNA complexed
to various aminoglycosides display crystal packings in which
the main intermolecular contacts occur between the bulging
adenines (A1492 and A1493) and the shallow/minor groove of
a neighbouring helix (11). The two adenines interact with the
30 ends of two adjacent helical Watson–Crick base pairs such
that the ﬁrst adenine (A1492) interacts in an antiparallel fash-
ion with one base of the Watson–Crick pair and the second
adenine (A1493) interacts in a parallel fashion with one base
of the next Watson–Crick pair. Such contacts have been called
A-minor motifs (25). The type I and type II names correspond
to the trans sugar-edge/sugar-edge or cis sugar-edge/sugar-
edge base pairs (26) (Figure 11). Two important points can
be raised: (i) A1493 interacts with both strands of the receptor
helix, whereas A1492 interacts only with one strand; (ii)
A1493 forms more H-bonds than A1492. In all crystal struc-
tures of RNA/Aminoglycoside complexes (the previous ones
(8–10) and those reported here), for at least one of the two
sites, the two bulging adenines form ideal A-minor motifs with
a neighbouring molecule (Supplementary Figure 3 shows a
Figure 10. DescriptionoftheemptyAsiteofthecrystallizedneaminecomplex.(A)Overallviewofsite2.A1408iscolouredindarkblue,A1492ingreen,A1493in
cyan, U1406 in orange and U1495 in magenta. (B and C) Atomic details of the base pair interactions into the empty minimal A site. Hydrogen bonds are shown as
dashed lines.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5687superimposition of all the structures). Although the packing is
more complicated for the neamine complex, A1492 and
A1493 of the bound site do form A-minor motifs with a neigh-
bouring duplex (Supplementary Figure 2).
DISCUSSION
It has been shown that aminoglycosides disturb the ﬁdelity of
the tRNA selection step by stabilizing a conformation similar
to that obtained for near-cognate complexes (4–6,12,27). In
other words, aminoglycosides provoke a structural rearrange-
ment of the decoding site from a state in which it accepts the
tRNA to a conformation which is productive for peptide bond
synthesis even in the absence of cognate mRNA/tRNA com-
plexes (7). Crystallographic structures of various 30S ribo-
somal particles and the present minimal A site complexes
bound to aminoglycosides (together with the previous ones)
offer different snapshots that helped to visualize atomic details
ofthemechanismofaction ofaminoglycosides.During decod-
ing, the A site changes its conformation from an ‘off’ con-
formation (with A1492 and A1493 folded into the shallow
groove of the A site) to an ‘on’ conformation (with A1492
and A1493 fully bulged out from the A site) (4–7). The crystal
structure of the neamine complex gives one possible view of
the ‘off’ conformation with a single adenine bulging out and
the other one paired within the A site. Recent elegant experi-
ments (24) coupling X-ray crystallography and ﬂuorescence of
2-amino purine substituted A1492 and A1493 fully conﬁrm
that interpretation. A different set of experiments (28), using
equilibrium dialysis of 20-O-methyl oligoribonucleotides
devised for binding to the A site of 30S particles, came to
a similar conclusion. The observed conformational change is
necessary to allow A1492 and A1493 to interact speciﬁcally
with the ﬁrst two of the three base pairs formed by the cognate
codon–anticodon interaction. The crystal packing observed in
all complexes display the same types of contacts between the
bulging adenines and Watson–Crick base pairs of a neighbour-
ing duplex. This observation was used to screen crystallo-
graphically compounds for speciﬁc binding to the A site. In
this way, modiﬁed aminoglycosides with activity against res-
istant bacteria could be crystallized and their structures solved
(29). The work on modiﬁed aminoglycosides (29), as well as
the data on the minimal inhibitory concentrations of natural
aminoglycosides (30,31) conﬁrm a posteriori the biological
relevance of the present crystal complexes and their validity as
models for the complexes between the 30S particles and
aminoglycosides (7). Our present observations further support
the view that the A site exists in a dynamic equilibrium
between conformations in which A1492 and A1493 are
fully bulged out and those in which only one base is bulging
out with the other one tucked inside the A site.
CONCLUSIONS
In the last ﬁve years, crystal structures of complexes between
various antibiotics and ribosomal particles or oligonucleotides
containing rRNA fragments [for a recent review, see (32)]
have offered us detailed views of the molecular recognition
between RNA targets and drugs. The comparative structural
analysis of this work leads to the following main conclusions:
(i) up to eight conserved contacts are observed in the com-
plexes; (ii) the conformations of the natural aminoglycosides
are always very similar; (iii) the aminoglycosides with the
Figure 11. Three-dimensionalstructureofthepackinginteractionsobservedintheneomycinBcrystalatthecentralWatson–Crickdomainoftheduplex.Thisview
showsacentralduplexinteractingwithtwosymmetry-relatedduplexesviathebulgedadenines.InbothAsites,A1492arecolouredingreen,A1493incyanandred
spheres indicate water molecules. Close-up of the interactions between each adenine and its counterpart G ¼ C pair (on the right magenta in site 1, top of central
drawing and, on the left orange in site 2, bottom of the central drawing). The hydrogen bonds are represented by black dashed lines.
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RNAs unspeciﬁcally in addition to speciﬁc binding.
(i) The conservation of contacts between the nine different
aminoglycosides, either 4,5 or 4,6 substituted, and the
ribosomal A site is clearly established. Despite the mole-
cular diversity in the antibiotics, key characteristic and
common interactions between aminoglycosides and the
A site are conserved: (a) the intercalation of ring I;
(b) the pseudo base pair between A1408 and ring I;
(c) the contacts between the nitrogens of the 2-DOS,
N1 to O4(U1495), N3 to N7(G1494), O2P(G1494),
O1P(A1493). Besides these six H-bonds, the contacts
between the hydroxyl groups O30 and O40 of ring I to
the phosphate groups of A1492 and A1493 occur depend-
ingon the presence ofthe hydroxyl groups. Itisstriking to
notice that the recent crystal structure of the complex
between the unrelated aminoglycoside apramycin and
the same oligonucleotide displayed, in addition to new
contacts, the same invariant contacts between the 2-
DOS as well as between the bicyclic ring II and the
same nucleotides A1408, G1494 and U1495 (33).
(ii) Variable contacts between the additional rings and the
RNA are formed depending on the number of the rings,
several of which are mediated by water molecules. The
overall conformations of the aminoglycosides are always
very similar; even when the aminoglycosides are bound
unspecifically at the edges of the A site (RMSD values
below 0.5 A ˚). This result is in stark contrast to the recent
crystal structures of complexes between the same oligo-
nucleotide and aminoglycosides modified at the 200
position by chains of various length (29) where a large
movement of rings III and IV could be observed. Thus,
natural aminoglycosides maintain the same exact confor-
mation in different binding modes in crystals, while they
areflexibleenoughtoformverydifferentconformationsin
other complexes with non-natural substitutions.
(iii) The least charged aminoglycosides among the nine struc-
tures (neamine, ribostamycin, geneticin and kanamycin
which have all four positive charges instead of five or
more for the other five aminoglycosides) display unusual
behaviours. In the geneticin crystal structure (10), alter-
native conformations of the sugar-phosphate backbone
were observed around 1492 and 1493. In the neamine
complex, an empty A site could be observed. In the ribos-
tamycin complex, each A site contained two bound anti-
biotics, while in the kanamycin complex, only one A site
contains two bound antibiotics. The binding modes of the
unspecificallyboundaminoglycosidesarenotcomparable
betweeneachother,possiblyreflectingthefactthatoneisa
4,5 and the other a 4,6 aminoglycoside. In any case, the
structures illustrate the difficulty of predicting the proper
stoichiometry of such complexes between oppositely
charged molecules, confirming recent data showing dis-
crepancies between measurements of affinity constants
andminimalinhibitoryconcentrations(30).Itisinteresting
toremarkthatbothribostamycinandkanamycinA,which
both present unspecific binding, present the largest disso-
ciation constantsin the family ofaminoglycosides studied
(34). Noticeable for drug design, the weakly charged
aminoglycosides with the least number of rings display
variable stoichiometries with unspecific binding. The
number of rings together with the number of positive
charges therefore contribute both to the formation of the
specific and high affinity 1:1 complexes.
In conclusion, the present comparative analysis of various
aminoglycosides bound tothe same ribosomalsite helped us to
decipher the contribution of each functional group to the spe-
ciﬁcity of the RNA/aminoglycoside complex and to derive
structurally-based rules for the mechanisms of binding and
action of that important family of antibiotics. However, the
analysis also revealed the difﬁculties and pitfalls in attempting
to rationalize the wealth of available thermodynamic binding
data on the basis of crystallographic data.
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